The U.S. Food and Drug Administration has approved an antibody, nirsevimab, which would protect newborns from R.S.V., respiratory syncytial virus....
#1 cause
The U.S. Food and Drug Administration has approved an antibody, nirsevimab, which would protect newborns from R.S.V., respiratory syncytial virus....
